Publications
5674 Results
- Journal / Conference
- Human Molecular Genetics Jan 15;25(2):371-381
- Year
- 2016
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID26604137
- PMC
- PMC4865031
- Study Number(s)
- S0000
Whole-exome sequencing of over 4100 men of African ancestry and prostate cancer risk
- Journal / Conference
- Cancer Apr 1;122(7):1017-1028
- Year
- 2016
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID26849082
- PMC
- PMC4803597
Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcoma
- Journal / Conference
- Medical Decision Making Jul;36(5):641-651
- Year
- 2016
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID27012232
- PMC
- PMC5963256
Development and evaluation of an approach to using value of information analyses for real-time prioritization decisions within SWOG, a large cancer clinical trials cooperative group
- Journal / Conference
- American Society of Clinical Oncology Educational Book 35:185-198
- Year
- 2016
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID27249699
- PMC
- PMC5495113
The role of clinical trial participation in cancer research: barriers, evidence, and strategies
- Journal / Conference
- JAMA Oncology Nov 1;2(11):1511
- Year
- 2016
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID: 27355398
- PMC
- PMC n/a - Correspondence
Measuring the real clinical impact of randomized clinical trials in oncology-reply: beyond citation counts [Comment and Response]
- Journal / Conference
- JAMA Surgery Jun 8:e161137
- Year
- 2016
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID27275632
- PMC
- PMC5210022
- Study Number(s)
- CTSU/A021101
Preoperative modified FOLFIRINOX treatment followed by capecitabine-based chemoradiation for borderline resectable pancreatic cancer: Alliance for Clinical Trials in Oncology Trial A021101
- Journal / Conference
- Journal of Geriatric Oncology 2016 Jul 25. pii: S1879-4068(16)30088-1. doi: 10.1016/j.jgo.2016.07.002 Jul 25 [Epub ahead of print]
- Year
- 2016
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID27468630
- PMC
- PMC5159186
- Study Number(s)
- SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415)
Validity of Adjuvant! Online in older patients with stage III colon cancer based on 2967 patients from the ACCENT database
- Journal / Conference
- New England Journal of Medicine Jul 21;375(3):209-219
- Year
- 2016
- Research Committee(s)
- Breast
- PMID
- PMID27264120
- PMC
- PMC5024713
- Study Number(s)
- JMA17
Extending aromatase-inhibitor adjuvant therapy to 10 years
- Journal / Conference
- American Journal of Hematology Mar;91(3):308-312
- Year
- 2016
- Research Committee(s)
- Leukemia
- PMID
- PMID26662208
- PMC
- PMC4806550
- Study Number(s)
- CTSU/E1908
A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908)
- Journal / Conference
- Journal of Clinical Oncology 34, 2016 (suppl 26S; abstr 44); ASCO Palliative Care in Oncology Symposium (Sept 9-10, 2016, San Francisco, CA), poster
- Year
- 2016
- Research Committee(s)
- Cancer Care Delivery